reglab/statecodes huggingface dataset:
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 2 - DRUGSTORES › Section 68-2-12a - Minimum requirements for library, equipment, and supplies

Current through Register Vol. 43, No. 28, July 11, 2024
(a) Each
			 registered pharmacy, other than a medical care facility pharmacy, shall have a
			 reference library, either immediately accessed by a computer or printed, that
			 is updated at least annually and that includes the following:
(1) A current copy of the Kansas pharmacy
			 practice act, the Kansas uniform controlled substances act, and the regulations
			 under both acts;
(2) a drug
			 information reference specifically drafted for patients, which may include the
			 "professional's guide to patient drug facts," published by facts and
			 comparisons, or "United States pharmacopeia dispensing information," volume II;
(3) one recognized reference in
			 toxicology, pharmacology, and drug interactions;
(4) one recognized reference in drug
			 equivalencies; and
(5) a medical
			 dictionary.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 2 - DRUGSTORES › Section 68-2-15 - Nametags

Current through Register Vol. 43, No. 28, July 11, 2024
(a) The
			 following individuals shall wear a visible nametag under the following
			 conditions:
(1) Each pharmacist, pharmacy
			 student, and intern, while performing pharmacist functions in a pharmacy; and
(2) each pharmacy technician,
			 while performing pharmacy technician functions in a pharmacy.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 2 - DRUGSTORES › Section 68-2-16 - Branches, agents and pickup stations

Current through Register Vol. 43, No. 28, July 11, 2024
No pharmacy nor pharmacist shall have, participate in, or
				permit an arrangement, branch, connection or affiliation whereby prescriptions
				are solicited, accepted, collected, or picked up, or advertised to be such,
				from or at any location other than a pharmacy for which a registration in good
				standing has been issued by the board.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 2 - DRUGSTORES › Section 68-2-19 - Prescription copies

Current through Register Vol. 43, No. 28, July 11, 2024
(A) No
			 registered pharmacist shall fill, and no pharmacy shall permit the filling of,
			 a copy of a prescription.
(B) Every
			 reference copy of a prescription shall bear the following legend "This
			 prescription copy is issued for reference only."
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 2 - DRUGSTORES › Section 68-2-20 - Pharmacist's function in filling a prescription

Current through Register Vol. 43, No. 28, July 11, 2024
(a) As used in
			 this regulation, each of the following terms shall have the meaning specified
			 in this subsection:
(1) "Prescriber" means a
			 "practitioner" as defined by
			 K.S.A.
			 65-1626 and amendments thereto, a "mid-level
			 practitioner" as defined by
			 K.S.A.
			 65-1626 and amendments thereto, or a person
			 authorized to issue a prescription by the laws of another state.
(2) "Legitimate medical purpose," when used
			 regarding the dispensing of a prescription drug, means that the prescription
			 for the drug was issued with a valid preexisting patient-prescriber
			 relationship rather than with a relationship established through an
			 internet-based questionnaire.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 2 - DRUGSTORES › Section 68-2-22 - Electronic transmission of a prescription

Current through Register Vol. 43, No. 28, July 11, 2024
(a) Each prescription drug order transmitted
			 electronically shall be issued for a legitimate medical purpose by a prescriber
			 acting within the course of legitimate professional practice.
(b) Each prescription drug order communicated
			 by way of electronic transmission shall meet these requirements:
(1) Be transmitted to a pharmacist in a
			 licensed pharmacy of the patient's choice, exactly as transmitted by the
			 prescriber;
(2) identify the
			 transmitter's phone number for verbal confirmation, the time and date of
			 transmission, and the identity of the pharmacy intended to receive the
			 transmission, as well as any other information required by federal and state
			 laws and regulations;
(3) be
			 transmitted by an authorized prescriber or the prescriber's designated agent;
			 and
(4) be deemed the original
			 prescription drug order, if the order meets the requirements of this
			 regulation.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 2 - DRUGSTORES › Section 68-2-23 - Notification to board; disciplinary action

Current through Register Vol. 43, No. 28, July 11, 2024
Each pharmacy owner shall notify the board in writing within 30
				days of any denial, limitation, suspension, revocation, voluntary surrender, or
				other disciplinary action taken by the state of Kansas or another jurisdiction
				against the pharmacy or the pharmacy owner or any application, license,
				registration, or permit held by the pharmacy owner.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 2 - DRUGSTORES › Section 68-2-24 - Pharmacy owner responsibilities

Current through Register Vol. 43, No. 28, July 11, 2024
(a)
			 Each pharmacy owner shall ensure that the pharmacy is operated in compliance
			 with the Kansas pharmacy act, the state and federal uniform controlled
			 substances act, the state and federal food, drug, and cosmetic act, the state
			 prescription monitoring program act, and all applicable regulations.
(b) Each pharmacy owner shall ensure that all
			 policies and procedures of the pharmacy are in compliance with the Kansas
			 pharmacy act, the state and federal uniform controlled substances act, the
			 state and federal food, drug, and cosmetic act, the state prescription
			 monitoring program act, and all applicable regulations.
(c) Each pharmacy owner shall not prohibit or
			 prevent a pharmacist, pharmacist intern, or pharmacy technician from complying
			 with the Kansas pharmacy act, the state and federal uniform controlled
			 substances act, the state and federal food, drug, and cosmetic act, the state
			 prescription monitoring program act, and all applicable regulations.
(d) Each pharmacy owner shall not penalize,
			 prohibit, or prevent a pharmacist from conducting an in-person inspection of a
			 prescription, drug or device, or product verification.
(e) Each pharmacy owner shall not permit an
			 individual to be in the pharmacy that has had a license or registration denied,
			 revoked, or suspended by the board, unless the licensee or registrant has
			 subsequently been issued an active license or registration by the
			 board.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 3 - RETAIL DEALER'S PERMIT › Section 68-3-5 - Retail dealer permit required

Current through Register Vol. 43, No. 28, July 11, 2024
A retail dealer may engage in the selling in Kansas of
				nonprescription drugs that are prepackaged, fully prepared by the manufacturer
				or distributor for use by the consumer, and labeled in accordance with the
				requirements of the state and federal food, drug, and cosmetic acts only if the
				retail dealer has obtained a permit to do so from the board.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 3 - RETAIL DEALER'S PERMIT › Section 68-3-6 - Minimum required information for permit

Current through Register Vol. 43, No. 28, July 11, 2024
(a) Each retail
			 dealer shall provide the board with the following minimum information as part
			 of the application for the permit required by
			 K.S.A.
			 65-1643(f), and amendments
			 thereto, and as part of any renewal of this permit:
(1) The name, full business address, and
			 telephone number of the permit holder;
(2) each trade or business name used by the
			 permit holder; and
(3) the
			 address, telephone number, and name of the contact person for each facility
			 used by the permit holder for the storage, handling, and distribution of drugs.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 5 - GENERAL RULES › Section 68-5-1 - Definitions

Current through Register Vol. 43, No. 28, July 11, 2024
The following words and phrases as used throughout these rules
				and regulations shall have the meanings specified below, unless otherwise
				indicated by the context of the specific regulation.
(a) Beyond-use date. The term "beyond-use
			 date" means a date placed on a prescription label at the time of dispensing,
			 repackaging, or prepackaging that is intended to indicate to the patient or
			 caregiver a time beyond which the contents of the prescription are not
			 recommended to be used.
(b)
			 Intern. The word "intern" means an individual who is a prospective candidate
			 for examination as a licensed pharmacist and who is qualified to receive and is
			 obtaining pharmaceutical experience as set forth in the pharmacy act of the
			 state of Kansas and its rules and regulations.
(c) Medication order. The term "medication
			 order" means an order by a prescriber for a registered patient of a Kansas
			 licensed medical care facility.
(d) Prescriber. The word "prescriber" means a
			 person who is authorized to issue a prescription order.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 5 - GENERAL RULES › Section 68-5-15 - Training of pharmacy technicians

Current through Register Vol. 43, No. 28, July 11, 2024
(a) The
			 pharmacist-in-charge of any pharmacy in which one or more pharmacy technicians
			 peform any tasks authorized by the pharmacy act shall insure that each pharmacy
			 technician complies with the training requirements in this regulation.
(b) The pharmacist-in-charge of
			 any pharmacy in which one or more pharmacy technicians perform any tasks
			 authorized by the pharmacy act shall insure that there exists for the pharmacy
			 a current pharmacy technician training course, designed for the functioning of
			 that pharmacy and addressing at least the following:
(1) Knowledge and understanding of the
			 different pharmacy practice settings;
(2) knowledge and understanding of the duties
			 and responsibilities of a pharmacy technician in relationship to other pharmacy
			 personnel and knowledge of standards, ethics, laws, and regulations governing
			 the practice of pharmacy;
(3)
			 knowledge and ability to identify and employ pharmaceutical and medical terms,
			 abbreviations, and symbols commonly used in prescribing and dispensing drugs
			 and in record keeping;
(4)
			 knowledge of and the ability to carry out calculations required for common
			 dosage determinations;
(5)
			 knowledge and understanding of the identification of drugs, drug dosages,
			 routes of administration, dosage forms, storage requirements, and manufacturer
			 recalls;
(6) knowledge of and the
			 ability to perform the manipulative and record-keeping functions involved in
			 and related to dispensing prescriptions or other drug distribution systems; and
(7) knowledge of and the ability
			 to perform procedures and techniques, including aseptic techniques, relating to
			 the compounding, packaging, and labeling of drugs.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 5 - GENERAL RULES › Section 68-5-16 - Ratio of pharmacy technicians to pharmacists

Current through Register Vol. 43, No. 28, July 11, 2024
The ratio of pharmacy technicians to pharmacists in any
				pharmacy shall not exceed four to one. A pharmacist shall not supervise at any
				time more than two pharmacy technicians who have not passed a certification
				examination approved by the board pursuant to
				K.A.R.
				68-5-17.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 5 - GENERAL RULES › Section 68-5-17 - Pharmacy technicians; certification examination; request for extension

Current through Register Vol. 43, No. 28, July 11, 2024
The following requirements shall apply to each individual who
				applies for a new pharmacy technician registration on or after July 1,
				2017:
(a) Each pharmacy technician
			 shall be required to pass either the pharmacy technician certification board
			 (PTCB) certification examination or the national health-career association
			 (NHA) ExCPT certification examination before the first renewal of the pharmacy
			 technician's registration.
(1) Each pharmacy
			 technician shall be required to attain a scaled score of at least 1400 on the
			 PTCB certification examination in order to pass.
(2) Each pharmacy technician shall be
			 required to attain a score of at least 390 on the NHA ExCPT certification
			 examination in order to pass.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 5 - GENERAL RULES › Section 68-5-18 - Pharmacy technicians; continuing education

Current through Register Vol. 43, No. 28, July 11, 2024
(a)
(1)
			 "Continuing education" shall mean an organized and systematic education
			 experience beyond basic preparation that is designed to achieve the following:
(A)
(i)
			 Increase knowledge, improve skills, or enhance the practice of pharmacy;
			 or
(ii) improve protection of the
			 public health and welfare; and
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-8 - Records

Current through Register Vol. 43, No. 28, July 11, 2024
(a) Each of the
			 following terms, as used in this regulation, shall have the meaning specified
			 in this subsection:
(1) "Digital image" means
			 the electronic record produced when a hard-copy prescription is scanned by a
			 computer and converted from human-readable format to a computer-readable
			 digital format and maintained as part of the prescription record in a pharmacy
			 prescription application.
(2)
			 "Electronic annotation" means a method to mark up a digital image or electronic
			 prescription to allow both notes and clarifications to be added to the
			 prescription record without altering the original digital
			 image.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-10 - Pharmacy-based drug distribution systems in long-term care facilities; emergency medication kits

Current through Register Vol. 43, No. 28, July 11, 2024
(a) Each
			 of the following terms, as used in this regulation, shall have the meaning
			 specified in this subsection:
(1) "Automated
			 drug delivery system" means an automated dispensing system, as defined by
			 K.S.A. 2017 Supp.
			 65-1626
			 and amendments thereto, that is located in a long-term care facility, uses a
			 robotic, mechanical, or computerized device to supply each drug to an
			 individual licensed by the board of healing arts or the board of nursing, who
			 shall administer the drug to a patient, and meets the requirements of
			 K.A.R.
			 68-9-3.
(2) "Formulary" means a prescription drug
			 list approved by the pharmacy and therapeutics committee or an equivalent
			 committee governing the security, control, and distribution of drugs within a
			 long-term care facility.
(3)
			 "Long-term care facility" means "nursing facility," as defined in
			 K.S.A.
			 39-923 and amendments thereto.
(4) "Traditional system" means a drug
			 distribution system in which the pharmacist receives a prescription order for
			 an individual patient and fills the prescription in any manner other than
			 packaging individual doses in unit-dose containers.
(5) "Unit-dose container" means a single-unit
			 or multiple-unit container for articles intended for administration in single
			 doses and directly from the container, by other than parenteral route.
(A) "Multiple-unit container" means a
			 container that permits the withdrawal of successive portions of the contents
			 without changing the strength, quality, or purity of the remaining
			 portion.
(B) "Single-unit
			 container" means a container that is designed to hold a quantity of a drug
			 intended for administration as a single dose promptly after the container is
			 opened.
(6) "Unit-dose
			 system" means a drug distribution system that is pharmacy-based and uses
			 unit-dose containers that enable distribution of packaged doses in a manner
			 that preserves the identity of the drug until the time of
			 administration.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-12 - Responsibility of pharmacist-in-charge in other than a medical care facility pharmacy

Current through Register Vol. 43, No. 28, July 11, 2024
Each pharmacist-in-charge for premises having a pharmacy
				registration, other than a medical care facility pharmacy, shall be responsible
				for the following functions:
(a) Each
			 pharmacist-in-charge shall develop or approve written policies and procedures
			 for the pharmacy that meet the following conditions:
(1) Provide adequate accountability and
			 control of drugs in compliance with the Kansas pharmacy act, the state and
			 federal uniform controlled substances act, and the state and federal food,
			 drug, and cosmetic act; and
(2)
			 ensure that any incident that occurs as a result of an alleged or real error in
			 filling or dispensing a prescription or medication order is brought to the
			 attention of the pharmacist-in-charge and completely documented in accordance
			 with K.A.R.
			 68-7-12b.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-12a - Nonresident pharmacies

Current through Register Vol. 43, No. 28, July 11, 2024
Each nonresident pharmacy shall meet the requirements of this
				regulation to be and remain registered in Kansas by the board.
(a)
(1) Each
			 pharmacy shall be currently licensed or registered in good standing in the
			 state in which it is located.
(2)
			 Each practicing pharmacist employed by or under contract with the pharmacy
			 shall be licensed as a pharmacist in the state where the pharmacist
			 practices.
(3) Each pharmacy shall
			 provide and maintain, in readily retrievable form, the record of a satisfactory
			 inspection conducted within the previous 18-month period by the licensing
			 entity of the state where the pharmacy is located. If no such inspection record
			 is readily available, the record of a satisfactory inspection conducted at the
			 expense of the pharmacy within the previous 18-month period by a third party
			 recognized by the board to inspect may be accepted.
(4) Each pharmacy shall designate a
			 pharmacist-in-charge, as defined by
			 K.S.A.
			 65-1626 and amendments thereto, who shall be
			 named in the application and who shall be responsible for receiving
			 communications from the board.
(A) The
			 pharmacist-in-charge shall timely respond to any lawful request for information
			 from the board or law enforcement authorities.
(B) The pharmacist-in-charge shall be
			 responsible for receiving and maintaining publications distributed by the
			 board.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-12b - Incident reports

Current through Register Vol. 43, No. 28, July 11, 2024
(a) For purposes
			 of this regulation, "reportable incident" and "incident" shall mean a
			 preventable medication error involving a prescription drug and resulting in any
			 of the following:
(1) The patient receiving
			 the wrong drug;
(2) the patient
			 receiving an incorrect drug strength;
(3) the patient receiving an incorrect dosage
			 form;
(4) the drug being received
			 by the wrong patient;
(5)
			 inadequate or incorrect packaging, labeling, or directions; or
(6) the dispensing of a drug to a patient in
			 a situation that results in or has the potential to result in serious harm to
			 the patient.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-13 - Pharmacist in charge of more than one location

Current through Register Vol. 43, No. 28, July 11, 2024
No pharmacist shall be a pharmacist in charge of more than one
				full-time pharmacy operation, which is defined as being one where the
				on-premises pharmacist services total 30 hours or more weekly.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-14 - Prescription labels

Current through Register Vol. 43, No. 28, July 11, 2024
(a) The
			 label of each drug or device shall be typed or machine-printed and shall
			 include the following information:
(1) The
			 name, address, and telephone number of the pharmacy dispensing the
			 prescription;
(2) the name of the
			 prescriber;
(3) the full name of
			 the patient;
(4) the identification
			 number assigned to the prescription by the dispensing pharmacy;
(5) the date the prescription was filled or
			 refilled;
(6) adequate directions
			 for use of the drug or device;
(7)
			 the beyond-use date of the drug or device dispensed;
(8) the brand name or corresponding generic
			 name of the drug or device;
(9) the
			 name of the manufacturer or distributor of the drug or device, or an easily
			 identified abbreviation of the manufacturer's or distributor's name;
(10) the strength of the drug;
(11) the contents in terms of weight,
			 measure, or numerical count; and
(12) necessary auxiliary labels and storage
			 instructions, if needed.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-15 - Packaging of drugs or devices in advance of immediate need

Current through Register Vol. 43, No. 28, July 11, 2024
All drugs or devices, whether in a unit-dose container or
				multiple-dose container, packaged in advance of immediate need shall meet the
				requirements of this regulation.
(a)
			 Packaging shall be done by a pharmacist or under the pharmacist's direct
			 supervision. The pharmacist shall verify and document verification of the
			 packaged drugs or devices before the packaged drugs or devices are released
			 from a facility registered with the board.
(b) Packaging shall be limited to the drugs
			 or devices dispensed from or supplied by the facility registered with the board
			 or in accordance with a shared services agreement.
(c) All containers used for packaging shall
			 preserve the stability and integrity of the drug or device. The storage
			 conditions of each packaged drug or device shall be maintained according to the
			 manufacturer's recommendations to preserve the stability and integrity of the
			 drug. The beyond-use date assigned to each packaged drug or device shall be the
			 manufacturer's expiration date, the maximum allowable beyond-use date for the
			 type of packaging material used, or not more than 12 months from the date of
			 packaging, whichever is earlier.
(d) An electronic or a written record shall
			 be established for lot numbers for recall purposes and shall be kept readily
			 retrievable in the facility registered with the board.
(e) If an area apart or separated from the
			 prescription drug area is used for packaging, the area shall be enclosed and
			 locked when a pharmacist is not in attendance in that area.
(f) In lieu of separately dispensing a drug
			 and an ingestible event marker approved by the food and drug administration to
			 monitor whether a patient is taking the drug as prescribed, any pharmacist may
			 use an ingestible event medication adherence package pursuant to a valid
			 prescription order or after obtaining the consent of the practitioner,
			 caregiver, or patient.
(g) For
			 purposes of this regulation, "ingestible event medication adherence package"
			 shall mean an ingestible unit-dose package designed to ensure medication
			 adherence that contains drugs from a manufacturer's original container and an
			 ingestible event marker, as defined by
			 21 C.F.R.
			 880.6305, effective February 1, 2022 and
			 hereby adopted by reference.
(h) In
			 addition to meeting the requirements of this regulation, all packaging of
			 sterile preparations shall meet the requirements of
			 K.A.R.
			 68-13-4.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-16 - Labels for drugs or devices packaged in advance of immediate need

Current through Register Vol. 43, No. 28, July 11, 2024
(a) Except as
			 specified in subsection (b), each label for a drug or device packaged in
			 advance of immediate need shall contain the following:
(1) The generic name of the drug or device
			 and the manufacturer's name. If the packaged drug or device bears a brand name,
			 the brand name may be substituted for the generic name of the drug or
			 device;
(2) the strength and
			 quantity of the drug or device;
(3)
			 the lot number, date of packaging, and the name of the individual responsible
			 for packaging;
(4) the beyond-use
			 date; and
(5) necessary auxiliary
			 labels.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-18 - Health departments and private not-for-profit family planning clinics

Current through Register Vol. 43, No. 28, July 11, 2024
The distribution and control of drugs provided by health
				departments and private not-for-profit family planning clinics authorized under
				K.S.A.
				65-1648(d)(1), and
				amendments thereto, shall conform to the following requirements:
(a) The approved drugs that may be stored and
			 distributed by health departments and not-for-profit family planning clinics
			 shall be only noncontrolled drugs that are approved by the food and drug
			 administration. In determining the formulary for each health department or
			 not-for-profit family planning clinic, the pharmacist-in-charge shall consult
			 with the medical supervisor and director of nursing for that facility. No state
			 or federal controlled drugs shall be allowed.
(b)
(1) The
			 pharmacist-in-charge shall review the procedures outlined below for the
			 distribution and control of all drugs within health department facilities and
			 family planning clinics and shall be responsible for the following:
(A) Ensuring the development of programs for
			 supervision of all personnel in the distribution and control of drugs;
(B) ensuring the development of a
			 policy and procedure manual governing the storage, control, and distribution of
			 drugs;
(C) maintaining
			 documentation of at least quarterly checks of drug records, drug storage
			 conditions, and drugs stored in all locations within the facility;
(D) establishing a drug recall procedure that
			 can be effectively implemented; and
(E) ensuring the development of written
			 procedures for maintaining records of distribution and prepackaging of drugs.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-19 - Transfer of a refillable prescription between pharmacies

Current through Register Vol. 43, No. 28, July 11, 2024
(a) As used in
			 K.S.A.
			 65-1656 and amendments thereto, the requested
			 or transferring pharmacy shall mean the pharmacy that has on file the original
			 refillable prescription that the patient wants to transfer to a second
			 pharmacy. The dispensing or requesting pharmacy shall mean the pharmacy that is
			 wanting the information transferred from the original refillable prescription
			 so that the patient may obtain the medication at this second pharmacy or the
			 pharmacy receiving the transferred prescription.
(b) Before any prescription is transferred,
			 the prescription information at the transferring pharmacy shall meet all of the
			 following conditions:
(1) The prescription
			 information indicates authorization for refilling by the prescriber.
(2) The drug on the prescription information
			 is not a schedule II controlled substance.
(3) The number of lawfully allowable refills
			 directed by the prescriber has not been exceeded.
(4) The maximum allowable time limit from the
			 original dating of the prescription has not been exceeded.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-20 - Shared services.

Current through Register Vol. 43, No. 28, July 11, 2024
(a)
(1) "Order" shall mean either of the
			 following:
(A) A prescription order as defined
			 in K.S.A.
			 65-1626, and amendments thereto; or
(B) a medication order as defined in
			 K.A.R.
			 68-5-1.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-21 - Institutional drug rooms

Current through Register Vol. 43, No. 28, July 11, 2024
(a) All
			 prescription-only drugs dispensed or administered from an institutional drug
			 room shall be in prepackaged units, the original manufacturer's bulk packaging,
			 or patient-specific pharmacy labeled packaging. All prepackaging shall meet the
			 requirements of K.A.R. 68-7-15 .
(b) Each pharmacist or practitioner, as that
			 term is defined in
			 K.S.A.
			 65-1637a and amendments thereto, who is
			 responsible for supervising an institutional drug room shall perform the
			 following:
(1) Develop or approve programs for
			 the training and supervision of all personnel in the providing and control of
			 drugs;
(2) develop or approve a
			 written manual of policies and procedures governing the storage, control, and
			 provision of drugs when a pharmacist or practitioner is not on duty;
(3) maintain documentation of at least
			 quarterly reviews of drug records, drug storage conditions, and the drugs
			 stored in all locations within the institutional drug room;
(4) develop or approve written procedures for
			 maintaining records of the provision and prepackaging of drugs; and
(5) develop or approve written procedures for
			 documenting all reportable incidents, as defined in K.A.R. 68-7-12b, and
			 documenting the steps taken to avoid a repeat of each reportable
			 incident.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-22 - Collaborative practice

Current through Register Vol. 43, No. 28, July 11, 2024
(a) Each
			 of the following terms, as used in this regulation, shall have the meaning
			 specified in this subsection:
(1)
			 "Collaborative drug therapy management" and "CDTM" mean a practice of pharmacy
			 in which a pharmacist performs certain pharmaceutical-related patient care
			 functions for a specific patient, and the functions have been delegated to the
			 pharmacist by a physician through a collaborative practice agreement.
(2) "Collaborative practice agreement" and
			 "CPA" mean a signed agreement or protocol voluntarily entered into between one
			 or more pharmacists and one or more physicians that provides for collaborative
			 drug therapy management.
(3)
			 "Pharmacist" means a person licensed, without limitation or restriction, to
			 practice pharmacy in Kansas.
(4)
			 "Physician" means a person who is licensed to practice medicine and surgery in
			 Kansas and who is a signing party to the pharmacist's CPA or
			 update.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-23 - Dispensing and administration of emergency opioid antagonist without a prescription

Current through Register Vol. 43, No. 28, July 11, 2024
(a) Any
			 pharmacist may dispense an emergency opioid antagonist and the necessary
			 medical supplies needed to administer an emergency opioid antagonist to a
			 patient, bystander, first responder agency, or school nurse without a
			 prescription, in accordance with the opioid antagonist protocol and this
			 regulation.
(b) Each pharmacist
			 dispensing an emergency opioid antagonist pursuant to this regulation shall
			 submit to the board a form provided by the board, within five days of signing
			 the opioid antagonist protocol, and shall maintain a signed and dated copy of
			 the opioid antagonist protocol, which shall be made available to the
			 pharmacist-in-charge, the board, and the board's designee. Each pharmacist that
			 no longer dispenses emergency opioid antagonists pursuant to the opioid
			 antagonist protocol shall notify the board, in writing, within 30 days of
			 discontinuation.
(c) Each emergency
			 opioid antagonist dispensed by a pharmacist shall be labeled in accordance with
			 the pharmacy practice act and any implementing regulations.
(d) Each pharmacist who dispenses an
			 emergency opioid antagonist pursuant to this regulation shall perform the
			 following:
(1) For each patient, bystander,
			 first responder agency, or school nurse to whom the emergency opioid antagonist
			 is dispensed, instruct that person or entity to summon emergency medical
			 services as soon as practicable either before or after administering the
			 emergency opi-oid antagonist;
(2)
			 for each patient or bystander to whom the emergency opioid antagonist is
			 dispensed, provide in-person counseling, training, and written educational
			 materials appropriate to the dosage form dispensed, including the following:
(A) Risk factors of opioid overdose;
(B) strategies to prevent opioid
			 overdose;
(C) signs of opioid
			 overdose;
(D) steps in responding
			 to an overdose;
(E) information on
			 emergency opioid antagonists;
(F)
			 procedures for administering an emergency opioid antagonist;
(G) proper storage, disposal, and expiration
			 date of the emergency opioid antagonist dispensed; and
(H) information on where to obtain a referral
			 for substance use disorder treatment; and
(3) for each first responder agency or school
			 nurse to whom the emergency opioid antagonist is dispensed, provide that person
			 or entity with written education and training materials that meet the
			 requirements of paragraphs (d)(1) and (2) and include the requirements to keep
			 inventory records and report any administration of the emergency opioid
			 antagonist to the appropriate healthcare provider pursuant to this
			 regulation.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 7 - MISCELLANEOUS PROVISIONS › Section 68-7-25 - Notification to board; pharmacist, pharmacy technician, or pharmacy intern

Current through Register Vol. 43, No. 28, July 11, 2024
Each pharmacist, pharmacy technician, and pharmacy intern shall
				notify the board in writing of any of the following circumstances within 30
				days of the date of occurrence:
(a)
			 Any conduct resulting in a charge of, arrest or indictment for, plea of guilty
			 or no contest to, diversion agreement, or suspended imposition of sentence
			 against the registrant or licensee that would constitute any of the following:
(1) Unprofessional conduct as defined by
			 K.S.A. 651626, and amendments thereto;
(2) a violation of the federal or state food,
			 drug, and cosmetic act; or
(3) a
			 violation of the Kansas uniform controlled substances act;
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 9 - AUTOMATED PRESCRIPTION SYSTEMS › Section 68-9-1 - Electronic data storage systems

Current through Register Vol. 43, No. 28, July 11, 2024
All electronic data storage systems operating within this state
				shall comply with the following requirements:
Automated Prescription Systems
(a) The pharmacist in charge of such a system
			 shall perform the following:
(1) Adopt a
			 written policy and procedures manual for control, use, and operation of the
			 system;
(2) assure that only
			 licensed pharmacists make decisions concerning judgmental functions as stated
			 in K.A.R. 68-2-20;
(3) be
			 responsible for all drug information within the system;
(4) assure that complete control over the
			 dispensing of medication is vested in licensed pharmacists;
(5) have an auxiliary procedure that shall be
			 used for documentation of refills of all prescription orders if the system
			 becomes inoperable. This auxiliary procedure shall insure that the following
			 criteria are met:
(A) Refills are authorized
			 by the original prescription order;
(B) the maximum number of refills has not
			 been exceeded; and
(C) a daily
			 backup is performed for use in restoring required information in case of a
			 system failure;
(6)
			 maintain a written prescription on file that preserves all information
			 contained in the original prescription. A machine-printed supplement that
			 provides all information necessary to comply with the law may be filed with or
			 attached to the written prescription, if the supplement does not obscure the
			 required information on the original prescription;
(7) provide a method of numerically
			 identifying each patient's written prescription;
(8) maintain the confidentiality of
			 prescriptions and assure that the system has adequate security and systems
			 safeguards to prevent unauthorized access, modification, or manipulation of
			 patient medication profile data; and
(9) maintain a written or electronic
			 prescription daily log. The daily log shall include the following information:
(A) The original prescription number;
(B) the date of the issuance of
			 the original prescription order by the practitioner;
(C) the full name and address of the patient;
(D) the name and address of the
			 practitioner;
(E) the
			 practitioner's DEA registration number if required;
(F) the name, strength, dosage form, and
			 quantity of the medication prescribed;
(G) the quantity dispensed, if different from
			 the quantity prescribed; and
(H)
			 the total number of refills authorized by the prescribing practitioner.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 9 - AUTOMATED PRESCRIPTION SYSTEMS › Section 68-9-3 - Automated drug delivery system to supply drugs for administration in certain facilities

Current through Register Vol. 43, No. 28, July 11, 2024
(a) Each
			 of the following terms, as used in this regulation, shall have the meaning
			 specified in this subsection:
(1) "Automated
			 drug delivery system" means an automated dispensing system, as defined by
			 K.S.A. 2017 Supp.
			 65-1626
			 and amendments thereto, that is located in a facility outside of a managing
			 pharmacy and uses a robotic, mechanical, or computerized device to supply each
			 drug to an individual licensed by the board of healing arts or the board of
			 nursing, who shall administer the drug to a patient.
(2) "Facility" means any of the following:
(A) A medical care facility, as defined in
			 K.S.A.
			 65-1626 and amendments thereto;
(B) an institutional drug room, as defined in
			 K.S.A. 651626 and amendments thereto; or
(C) a long-term care facility, which shall
			 mean any of the following:
(i) A nursing
			 facility, as defined in
			 K.S.A.
			 39-923 and amendments thereto;
(ii) a nursing facility for mental health, as
			 defined in
			 K.S.A.
			 39-923 and amendments thereto; or
(iii) any other type of adult care home, as
			 defined in
			 K.S.A.
			 39-923 and amendments thereto, that is not
			 specified in paragraphs (a)(2)(C)(i) and (ii) and, after submitting an
			 application, is approved by the board for an automated drug delivery
			 system.
(3)
			 "Managing pharmacy" means a pharmacy located in Kansas.
(4) "Pharmacist-in-charge" means the
			 pharmacist-in-charge of the managing pharmacy.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 11 - FEES › Section 68-11-1 - Fees for examination and licensure as a pharmacist

Current through Register Vol. 43, No. 28, July 11, 2024
The following fees shall be paid to the board by each applicant
				for examination and licensure as a pharmacist:
(a) Each applicant for examination shall pay
			 a fee of $100.00.
(b) Each
			 applicant for reciprocal licensure shall pay a fee of $125.00.
(c) An additional fee of $250.00 to evaluate
			 the education and training shall be paid by each applicant for reciprocal
			 licensure or examination who graduated from a school or college of pharmacy or
			 department of a university not approved by the board.
(d) Each licensed pharmacist shall pay a
			 renewal fee of
$150.00.
(e) The penalty fee for a late renewal of a
			 pharmacist license shall be $200.00.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 11 - FEES › Section 68-11-2 - Fees for premises and service registrations and permits

Current through Register Vol. 43, No. 28, July 11, 2024
(a) Pharmacy registration fees shall be as
			 follows:
(1) Each new pharmacy registration
			 shall be $150.00.
(2) Each renewal
			 pharmacy registration shall be $125.00.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 11 - FEES › Section 68-11-3 - Fees for registration as a pharmacy technician or pharmacy intern

Current through Register Vol. 43, No. 28, July 11, 2024
The following fees shall be paid to the board:
(a) Each applicant for initial registration
			 as a pharmacy technician shall pay a fee of $20.00.
(b) Each registered pharmacy technician shall
			 pay a renewal fee of $20.00.
(c)
			 Each applicant for a pharmacy intern registration shall pay a fee of
			 $20.00.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 12 - RESALE OF MEDICATION › Section 68-12-2 - Resale of dispensed prescription drugs

Current through Register Vol. 43, No. 28, July 11, 2024
Except for prescription drugs in unit-dose systems that contain
				only one medication and in which the drug has not reached the patient and is
				still intact, prescription drugs that have been dispensed to the final consumer
				shall not be resold, redispensed, or distributed by a licensed pharmacist.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 13 - PARENTERAL PRODUCTS › Section 68-13-3 - Nonsterile preparations

Current through Register Vol. 43, No. 28, July 11, 2024
(a) This
			 regulation shall apply to the following:
(1)
			 Nonsterile preparations that are compounded in Kansas; and
(2) nonsterile preparations that are shipped
			 or delivered into Kansas by a pharmacy and are to be administered to a patient
			 in Kansas.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 13 - PARENTERAL PRODUCTS › Section 68-13-4 - Sterile preparations

Current through Register Vol. 43, No. 28, July 11, 2024
(a)
			 This regulation shall apply to the following:
(1) Sterile preparations that are compounded
			 in Kansas; and
(2) sterile
			 preparations that are shipped or delivered into Kansas by a pharmacy to be
			 administered to a patient in Kansas.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 14 - WHOLESALE DISTRIBUTORS › Section 68-14-2 - Definitions

Current through Register Vol. 43, No. 28, July 11, 2024
As used in this article of the board's regulations and the
				pharmacy practice act, each of the following terms shall have the meaning
				specified in this regulation:
(a)
			 "Blood" means whole blood collected from a single donor and processed either
			 for transfusion or for further manufacturing.
(b) "Blood component" means that part of
			 blood separated by physical or mechanical means.
(c) "Common ownership and control" means the
			 power to direct or cause the direction of the management and policies of a
			 person or an organization, whether by ownership of stock, by voting rights, by
			 contract, or by other means.
(d)
			 "Drug sample" means a unit of a prescription-only drug that is not intended to
			 be sold, is intended to promote the sale of the drug, and is distributed on a
			 gratuitous basis.
(e) "Device" has
			 the meaning specified in K.S.A. 65656, and amendments thereto.
(f) "Emergency medical reasons" shall include
			 transfers of prescription-only drugs by a retail pharmacy to another retail
			 pharmacy to alleviate a temporary shortage, except that the gross dollar value
			 of these transfers shall not exceed five percent of the total prescription-only
			 drug sales revenue of either the transferor or transferee pharmacy during any
			 period of 12 consecutive months.
(g) "Excursion" means a deviation from the
			 range of temperatures specified by the manufacturer for storage or transport of
			 a prescription-only drug or device based on stability data.
(h) "Intracompany sales" and "intracompany
			 distribution" mean any transaction or transfer between any division,
			 subsidiary, parent, affiliated, or related company under the common ownership
			 and control of a corporate entity.
(i) "Primary owner" means any person owning
			 or controlling more than 50 percent of the wholesaler's business.
(j) "Room temperature" means a temperature
			 that is maintained thermostatically and meets the following requirements:
(1) Encompasses the usual and customary
			 working environment of 20° to 25°C (68° to 77°F);
(2) results in a mean kinetic temperature
			 calculated to be not more than 25°C (77°F); and
(3) allows for excursions between 15° and
			 30°C (59° to 86°F) experienced in facilities, such that the
			 allowable calculated mean kinetic temperature remains in the allowed
			 range.
Kansas Administrative Regulations › Agency 68 - KANSAS STATE BOARD OF PHARMACY › Article 14 - WHOLESALE DISTRIBUTORS › Section 68-14-5 - Personnel

Current through Register Vol. 43, No. 28, July 11, 2024
(a) Each wholesale
			 distributor registrant, virtual wholesale distributor registrant, third-party
			 logistics registrant, or outsourcing facility registrant shall require each
			 person employed in any wholesale distribution, virtual wholesale distribution,
			 third-party logistics, or outsourcing activity, or any combination of these
			 activities, to receive education, training, and experience sufficient for that
			 person to perform the assigned functions in a manner providing assurance that
			 the drug product quality, safety, and security will at all times be maintained
			 as required by law. Each registrant shall maintain records of the training,
			 education, and experience for five years.
(b) Each wholesale distributor registrant,
			 virtual wholesale distributor registrant, or third-party logistics provider
			 registrant shall designate an individual as the facility manager, who shall be
			 responsible for all aspects of the registrant's operation.
(c) Each outsourcing facility registrant
			 shall designate a pharmatist-in-charge, as defined by
			 K.S.A.
			 65-1626 and amendments thereto, who shall be
			 responsible for all aspects of the registrant's operation.